0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Insulin R

Insulin R

Insulin R Molecule Information

Name:Insulin receptor
Target Synonym:Insulin receptor subunit alpha;Insulin receptor subunit beta;Insulin receptor;IR;CD_antigen=CD220;INSR
Number of Launched Drugs:48
Number of Drugs in Clinical Trials:105
Lastest Research Phase:Approved

Insulin R Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
INR-H52Ha Human Human Insulin R / CD220 (28-944) Protein, His Tag (SPR verified)
INR-H52Ha-structure
INR-H52Ha-sds
INR-H52Ha-elisa_1
INR-H52Ha-elisa_2

Insulin R Part of Bioactivity data

INR-H52Ha-SPR
Human_FcRn_Heterodimer_Protein_SPR

Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) captured on CM5 chip via anti-His antibody, can bind Human Insulin with an affinity constant of 249 nM as determined in a SPR assay (Biacore T200) (QC tested).

INR-H52Ha-ELISA
Human Insulin R (28-944), His Tag (SPR verified)Human Insulin R (28-944), His Tag (SPR verified) (Cat. No. INR-H52Ha) ELISA bioactivity

Immobilized Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) at 5 μg/mL (100 μL/well)can bind Human IGF-II, Fc Tag (Cat. No. IG2-H4260) with a linear range of 0.078-1.25 μg/mL (QC tested).

Insulin R Molecule Synonym Name

INSR,Insulin receptor,IR,CD220

Insulin R Molecule Background

Insulin receptor (INSR) is also known as CD antigen CD220, which can be cleaved into the following 2 chains: Insulin receptor subunit alpha and Insulin receptor subunit beta. INSR is a tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain. Forms a hybrid receptor with IGF1R, the hybrid is a tetramer consisting of 1 alpha chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of IGF1R. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short of INSR has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, INSR binds IGF1.

Insulin R References

Insulin R Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Rinsulin NPH (Geropharm) Approved GEROPHARM Diabetes Details
Insulin degludec NN-1250; Insulin-454,NN1250 Approved Novo Nordisk Insulin degludec 日本 Diabetes 诺和诺德 2012-09-28 00:00:00.0 Diabetes, Type 1 diabetes, Type 2 diabetes Details
Human insulin biosimilar (Square Pharmaceuticals) Approved Square Pharmaceuticals Diabetes Details
Oral insulin (Generex Biotechnology) Approved Generex Biotechnology Corporation, SciVac Ltd, PharmaBrand, DongSung Pharm Type 1 diabetes, Type 2 diabetes Details
Recombinant human insulin (Shenzhen Kexing Biotech) Approved Shenzhen kexing, Shenzhen kexing Diabetes Details
Insulin glargine biosimilar (Lilly/Boehringer Ingelheim) LY-2963016; LY2963016-U-100; LY2963016-U-200,LY2963016 Approved Lilly, Boehringer Ingelheim insulin glargine ema

Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.

Eli Lilly Nederland B.V. 2014-09-09 Type 1 diabetes, Type 2 diabetes Details
Recombinant human insulin (SciGen) Approved Generex Biotechnology Corporation, SciVac Ltd Diabetes Details
Human insulin biosimilar (MJ Biopharm) Approved MJ Biopharm Pvt Diabetes Details
Recombinant Human Insulin (Wanbang Pharma) Approved Wanbang Biopharmaceuticals Recombinant Human Insulin Injection cfda Diabetes 2015-08-25 Diabetes Details
Insulin biosimilar (Julphar) Approved Julphar Gulf Pharmaceutical Industries Diabetes Details
Ceritinib LDK-378; NVP-LDK378; NVP-LDK378-NX,LDK378,LDK 378 Approved Novartis ZYKADIA fda Non small cell lung cancer (NSCLC) NOVARTIS 2014-04-29 Non small cell lung cancer (NSCLC) Details
Insulin human (rDNA origin, Novo Nordisk) NN-729,NN729 Approved Novo Nordisk Mixtard 50/50 hma Diabetes Novo Nordisk A/S
Novo Alle
DK-2880 Bagsv?rd
1996-07-29 Diabetes Details
Isophane Protamine Recombinant Human Insulin Injection (Shenzhen Kexing Biotech) Approved Shenzhen kexing Isophane Protamine Recombinant Human Insulin Injection cfda Diabetes 2015-04-30 Diabetes Details
Rosinsulin Approved Medsintez Diabetes Details
Insulin glargine biosimilar (Incepta Pharmaceuticals) Approved Incepta Pharmaceuticals Type 1 diabetes, Type 2 diabetes Details
Insulin biosimilar (Harvest Moon Pharmaceuticals) Approved Harvest Moon Diabetes Details
Insulin aspart NN-1218; INA-X14; Insulin X14 Approved Novo Nordisk insulin aspart ema

NovoRapid is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Novo Nordisk A/S 1999-09-07 Diabetes Details
Insulin N biosimilar (Popular Pharmaceuticals) Approved Popular Pharmaceuticals Diabetes Details
Insulin glargine biosimilar (LG Life Sciences) Approved LG Life Sciences, Lupin Type 1 diabetes, Type 2 diabetes Details
Recombinant lispro insulin biosimilar (Gan & Lee) Approved Gan & Lee Biotech Recombinant Lispro Insulin Injection cfda Diabetes 2015-11-30 Diabetes Details
Insulin biosimilar (Popular Pharmaceuticals) Approved Popular Pharmaceuticals Diabetes Details
Isophane Insulin Approved Wanbang Biopharmaceuticals Isophane Insulin Injection cfda Diabetes 2015-08-25 Diabetes Details
Recombinant human insulin (Incepta) Approved Incepta Pharmaceuticals Diabetes Details
Insulin aspart biosimilar (Sanofi) SAR 341402; SAR-Asp Approved Sanofi insulin aspart ema

Insulin aspart Sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

sanofi-aventis groupe 2020-06-25 Type 1 diabetes, Type 2 diabetes Details
Insulin lispro LY-275585; Lys-B28; Pro-B29; LYSPRO; LY-900027 Approved Lilly insulin lispro ema Eli Lilly Nederland B.V. 1996-04-30 Diabetes Details
Recombinant human insulin (Biocon) Approved Biocon Diabetes Details
Insulin human HR-1799 Approved Sanofi Deutschland insulin human ema Sanofi-aventis Deutschland GmbH 2007-01-17 Diabetes, Cerebral edema diabetic ketoacidosis Details
Insulin biosimilar (Sedico) Approved Sedico Diabetes Details
Insulin degludec/Insulin aspart NN-5401; NN-1045; NN-1250/Insulin aspart Approved Novo Nordisk A/S Insulin degludec/Insulin aspart 日本 Diabetes 诺和诺德 2012-12-25 00:00:00.0 Diabetes, Type 1 diabetes, Type 2 diabetes Details
Insulin detemir NN-304 Approved Novo Nordisk Insulin detemir ema

Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Novo Nordisk A/S 2004-06-01 Type 1 diabetes, Diabetes Details
Recombinant insulin (Horizon Pharma/Ibatech) Approved Savient Pharmaceuticals, Horizon, Ibatech Sp. zo.o Type 1 diabetes Details
Insulin degludec/Liraglutide NN-9068,NN9068 Approved Novo Nordisk insulin degludec;liraglutide ema Novo Nordisk A/S 2014-09-18 Type 2 diabetes Details
Insulin glargine biosimilar (Wockhardt) Approved Wockhardt Diabetes, Type 1 diabetes, Type 2 diabetes Details
Recombinant insulin glargine (Gan & Lee) Approved Gan & Lee Biotech Recombinant Insulin Glargine Injection cfda Diabetes 2015-02-03 Diabetes Details
Insulin glargine biosimilar (Getz Pharma) Approved Getz Pharma Type 1 diabetes, Type 2 diabetes Details
Insulin lispro biosimilar (Sanofi) SAR-342434 Approved Sanofi insulin lispro ema sanofi-aventis groupe 2017-07-18 Diabetes Details
Insulin glulisine HMR-1964,HMR1964 Approved Sanofi APIDRA fda Type 1 diabetes, Diabetes SANOFI AVENTIS US 2004-04-16 Type 1 diabetes, Diabetes Details
Insul 30/70 biosimilar (Popular Pharmaceuticals) Approved Popular Pharmaceuticals Type 1 diabetes, Gestational diabetes mellitus, Type 2 diabetes Details
Bacitracin Approved Pfizer Bacterial infection Details
Insulin glargine biosimilar (Biocon) MYL-1501D Approved Biocon BioPharmaceuticals, FUJIFILM Corporation, Mylan 日本 Diabetes FUJIFILM Corporation 2016-03-28 00:00:00.0 Diabetes Details
Insulin glargine biosimilar (Merck Sharp & Dohme) MK-1293; SB-9 Approved Samsung Bioepis, Merck Sharp & Dohme insulin glargine ema

Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.

Merck Sharp & Dohme B.V. 2017-01-03 Type 1 diabetes, Type 2 diabetes Details
Recombinant human insulin (Tonghua Dongbao Pharmaceutical) Approved Tonghua Dongbao Pharmaceutical Isophane Protamine Recombinant Human Insulin Injection cfda Diabetes 2015-08-18 Diabetes Details
Insulin human (inhalation powder) SAR-439065,SAR439065 Approved MannKind Corporation, Sanofi AFREZZA fda Diabetes MANNKIND 2014-06-27 Diabetes Details
Insulin human (rDNA origin, Lilly) S-3300; LY-041001; U-500R Approved Lilly HUMULIN R fda Diabetes LILLY 1982-10-28 Diabetes Details
Recombinant human insulin (United Laboratories International Holdings) Approved United Laboratories Zhongshan Branch Isophane Protamine Recombinant Human Insulin Injection cfda Diabetes 2014-11-24 Diabetes Details
Insulin glargine Gla-100; Gla-300; HOE901-U300; Hoe-71GT; Hoe-901; U-300 Approved Sanofi LANTUS SOLOSTAR fda Type 2 diabetes, Type 1 diabetes SANOFI AVENTIS US 2000-04-20 Diabetes, Type 1 diabetes, Type 2 diabetes Details
Insulin biosimilar (Wockhardt) Approved Wockhardt Type 1 diabetes Details
Insulin glargine/Lixisenatide HOE-901/AVE-0010 Approved Sanofi SOLIQUA 100/33 fda Type 2 diabetes SANOFI-AVENTIS US 2016-11-21 Type 2 diabetes Details
Insulin lispro protamine biosimilar (Gan & Lee Pharmaceuticals) Approved Gan & Lee Biotech Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection(25R) cfda Diabetes 2014-05-09 Diabetes Details

Insulin R Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Recombinant human insulin (HEC Pharm) BLA Filing HEC Pharm, Yichang HEC Changjiang Pharmaceutical Diabetes Details
INS-061 INS-061; HS-061 IND Filing Shanghai Hengrui Diabetes Details
Insulin icodec 148-0287-A; Insulin-287; LAI-287; Long-acting basal insulin analogue; Long-acting-insulin-287; NN-1436; NN-1956; NNC-0148-0000-0287; NNC0148-0287 C; OI-287GT Phase Ⅲ Novo Nordisk Type 2 diabetes Details
Insulin glargine biosimilar (YiChang HEC ChangJiang Pharmaceutical) Phase Ⅲ HEC Pharm, Lannett Diabetes Details
Stem cell therapy (RejuvaCell) Phase Not Specified RejuvaCell Type 2 diabetes Details
Insulin lispro/Insulin glargine Phase Ⅱ Adocia Type 1 diabetes, Type 2 diabetes Details
Insulin detemir biosimilar (Tonghua Dongbao Pharmaceutical) Phase Ⅰ Tonghua Dongbao Pharmaceutical Diabetes Details
Insulin prandial injectable (Albireo Pharma) VIAject-25; VIAject-7 BLA Filing Albireo Type 1 diabetes, Diabetes, Type 2 diabetes Details
Insulin oral (Emisphere Technologies) Phase Ⅱ Emisphere Technologies Type 2 diabetes Details
Insulin aspart biosimilar (Gan & Lee) BLA Filing Gan & Lee Biotech Type 1 diabetes, Type 2 diabetes Details
NN-1406 NN-1406; NNC0143-0406; NNC0143-0406 A; PI-406 Phase Ⅰ Novo Nordisk Type 1 diabetes, Type 2 diabetes Details
Insulin glargine biosimilar(Shandong New Time Pharmaceutical) BLA Filing Lunan Pharmaceutical Group Corporatio Diabetes Details
Insulin (Oramed Pharmaceuticals) ORMD-0801 Phase Ⅱ Oramed Pharmaceuticals, Hefei Tianhui Incubator of Technologies Type 1 diabetes, Type 2 diabetes Details
Bacitracin/Tranexamic acid IPI-120 Preclinical Imprimis Pharmaceuticals wound, Wound infections Details
Recobinant human proinsulin C peptide (Shanghai Newsummit/Shanghai Yizhong) Phase Ⅰ Shanghai Newsummit Biopharma Diabetic nephropathy Details
Insulin lispro (Diasome Pharmaceuticals) Phase Ⅱ Diasome Pharmaceuticals Type 1 diabetes Details
Transdermal insulin patch (Dermisonics) Phase Ⅰ Dermisonics, Encapsulation Systems, Transdermal Global Diabetes Details
Insulin biosimilar (Hefei Tianmai Biotechnology) Phase Ⅲ Hefei Tianmai Biotechnology Diabetes Details
Insulin adjustable basal (Biodel) BIOD-809 Phase Ⅰ Albireo Diabetes Details
Transdermal insulin patches (SK Chemicals) Phase Ⅲ SK Chemicals Type 1 diabetes Details
Insulin glargine biosimilar (Wanbang Biochemical) Phase Ⅲ Wanbang Biopharmaceuticals Type 2 diabetes Details
DM199 DM-199; DM-99 Phase Ⅱ DiaMedica Stroke, Type 2 diabetes, Chronic kidney disease Details
PE-0139 PE-0139 Phase Ⅱ PhaseBio Type 2 diabetes Details
Ultra-rapid-acting insulin analogue (Albireo Pharma) BIOD-238 Phase Ⅰ Albireo Type 1 diabetes Details
Insulin transdermal (TransPharma Medical) Phase Not Specified TransPharma Medical Type 1 diabetes, Type 2 diabetes Details
Transbuccal insulin (MidaSol) MSRX-301; MSL-001; MTD-101 Phase Ⅱ Midatech, Aquestive Therapeutics Type 1 diabetes Details
Basal insulin peglispro LY-2605541,LY2605541 Phase Ⅲ Lilly, Boehringer Ingelheim Type 1 diabetes, Type 2 diabetes Details
Insulin mouth rinse (EastGate Biotech) Phase Ⅲ Eastgate Biotech, Genome Pharmaceuticals Type 1 diabetes, Type 2 diabetes, Alzheimer's disease (AD) Details
Recombinant human insulin biosimilar (Rechon Life Sciences) Phase Ⅲ Rechon Life Science Type 1 diabetes Details
KW-2450 KW-2450 Phase Ⅱ Kyowa Hakko Kirin Breast cancer Details
Recombinant insulin aspart biosimilar (Biogenomics) Phase Ⅲ Biogenomics Type 2 diabetes Details
Ultra fast-acting insulin analogue BC-106-Insulin-Lispro; BC-222-Insulin-Lispro Phase Ⅲ Adocia, Lilly, Tonghua Dongbao Pharmaceutical Type 1 diabetes, Type 2 diabetes Details
Insulin receptor-regulating antibodies (XOMA) X-129; XMet program; XMetA; XMetD;XMetS; XOMA-129 Preclinical Xoma Diabetes, Hypoglycemia Details
SAR-161271 SAR 161271,SAR-161271,SAR161271 Phase Ⅱ Sanofi Type 1 diabetes Details
NN-344 NN-344 Phase Ⅰ Novo Nordisk A/S Type 1 diabetes, Type 2 diabetes Details
Insulin inhalation (Aerogen) Phase Ⅱ Nektar Diabetes Details
Insulin rectal (Oramed Pharmaceuticals) ORMD-0802 Phase Ⅰ Oramed Pharmaceuticals Type 1 diabetes Details
Oral insulin (Purede) Phase Not Specified Puredel Diabetes Details
Insulin glargine biosimilar (Tonghua Dongbao Pharmaceutical) BLA Filing Tonghua Dongbao Pharmaceutical Diabetes Details
Human insulin biosimilar (Marvel Lifesciences) BLA Filing Marvel LifeSciences Private Diabetes Details
Fast-acting human insulin (Adocia) BioChaperone-222; Hinsbet-U500 Phase Ⅱ Adocia Type 1 diabetes Details
Recombinant human insulin (Nutrinia) NTRA-9620,NTRA 9620,NTRA9620 Phase Ⅲ Nutrinia Short bowel syndrom Details
Insulin lispro biosimilar (Valin Technologies) Preclinical Valin Technologies Diabetes Details
Insulin polysialic (Xenetic Biosciences) SYN-20090110-RU; SYN-20090510-RU Phase Ⅰ Lipoxen Technologies, SynBio, Xenetic Biosciences Type 1 diabetes, Central nervous system disorders, Type 2 diabetes Details
Insulin biosimilars (Bioton) Phase Not Specified Bioton Diabetes Details
Insulin inhalation (Andaris) Phase Ⅰ Elan Corporation Diabetes Details
Oral insulin-338-C10 Insulin-338-GIPET-I; LAI-338; NN-1438; NN-1953; NNC0123-0338; OI-338GT; Oral insulin 338 C10 Phase Ⅱ Novo Nordisk, Merrion Pharmaceuticals Type 1 diabetes, Type 2 diabetes Details
Ultra-rapid-acting insulin analogues (Albiero Pharma) BIOD-250 Phase Ⅰ Albireo Type 1 diabetes Details
Dulaglutide/Basal insulin Fc Phase Ⅰ Lilly Diabetes Details
Linsitinib ASP-7487; OSI-906; OSI-906AA,ASP7487,OSI906,OSI906AA Phase Ⅲ Astellas, National Cancer Institute Adrenocortical carcinoma Details
Insulin biosimilar (Valin Technologies) Van-101,Van 101,Van101 Phase Ⅲ Valin Technologies Diabetes Details
EX-1000 EX1000,EX 1000 Phase Ⅱ Novo Nordisk Type 2 diabetes Details
Insulin human (Pfizer) HMR 4006 Withdrawn Pfizer, Nektar Diabetes Details
Insulin aspart biosimilar (Zhuhai United Laboratories) BLA Filing United Laboratories Type 1 diabetes, Type 2 diabetes Details
INS-068 INS-068,INS068; INS 068 Phase Ⅰ Jiangsu Hengrui Medicine, Chengdu Shengdi, Shanghai Hengrui Type 1 diabetes, Type 2 diabetes Details
Insulins (Halozyme) Analog insulin-PH20; Aspart-PH20;Insulin-PH20; Lispro-PH20; rHuPH20/insulin Phase Ⅱ Halozyme Therapeutics Type 1 diabetes, Type 2 diabetes Details
Intranasal insulin (Johns Hopkins University) Phase Ⅱ Johns Hopkins University HIV-associated neurocognitive disorder, Multiple sclerosis (MS) Details
Insulin (Altea Therapeutics) AT-1391 Phase Ⅱ Nitto Denko Type 1 diabetes, Type 2 diabetes Details
Human insulin/EDTA/Citrate/Magnesium sulfate (Biodel) BIOD-123 Phase Ⅱ Albireo Type 1 diabetes Details
MK-2640 MK-2640,MK2640,MK 2640 Phase Ⅰ Merck Sharp & Dohme Type 1 diabetes Details
recombinant human insulin CKD-401,CKD 401,CKD401 Phase Ⅲ Chong Kun Dang Diabetes Details
Insulin glargine biosimilar (Valin Technologies) Phase Ⅰ Valin Technologies Diabetes Details
AB-101 (Rezolute) AB-101 Phase Ⅰ IPR Pharmaceuticals, Rezolute, Xoma Type 1 diabetes Details
重组赖精胰岛素(合肥天麦) Phase Ⅲ Hefei Tianmai Biotechnology Diabetes Details
Insulin inhalation (MAP Pharmaceuticals) MAP-0001 Phase Ⅰ Allergan Type 1 diabetes, Type 2 diabetes Details
Insulin biosimilar (University of Montreal Health Centre) Phase Ⅰ University of Montreal Health Centre Glaucoma Details
Insulin oral (Diabetology) DTY-001 Phase Ⅱ Diabetology Ltd, USV Type 1 diabetes, Type 2 diabetes Details
NN-1954 (Novo Nordisk) NN-1954 Phase Ⅰ Novo Nordisk Type 1 diabetes, Type 2 diabetes Details
Concentrated ultra-rapid-acting insulin (Albireo Pharma) BIOD-531 Phase Ⅱ Albireo Type 2 diabetes Details
Insulin glargine biosimilar (Geropharm) Phase Ⅲ GEROPHARM Type 1 diabetes, Type 2 diabetes Details
NKTR-034 NKTR-034 Phase Ⅰ Nektar Diabetes Details
BetaRx Phase Ⅱ Vivorx Pharmaceuticals Diabetes Details
HM-12460A HM-12470; HM-12470A; SAR-440067 Phase Ⅰ Hanmi Type 1 diabetes, Type 2 diabetes Details
Insulin inhaled (Translational Research) Phase Ⅰ Translational Research Ltd Type 1 diabetes Details
Insulin inhalation (Abbott Laboratories) KI-02212; KI-02-212 Phase Ⅱ Abbott Diabetes Details
Ultra fast-acting insulin lispro biosimilar (Perosphere) URAL Phase Ⅰ Perosphere Type 1 diabetes Details
AI-401 AI-401 Phase Ⅲ The National Institute of Diabetes and Digestive and Kidney Diseases Type 1 diabetes Details
Pegylated recombinant human insulin (Chongqing Fujin Biomedical) Phase Ⅰ Chongqing Fujin Biomedical Diabetes Details
Insulin lispro biosimilar (Wanbang Biopharma) Phase Ⅲ Wanbang Biopharmaceuticals Diabetes Details
CLX-0901 CLX 0901 Phase Ⅱ Theracos Type 2 diabetes Details
Insulin aspart biosimilar (Geropharm) GP-40071; GP-40081 Phase Ⅲ GEROPHARM Diabetes Details
Alirinetide GM-6; GM-600; GM-602; GM-603; GM-604; GM-605; GM-606; GM-607; GM-608; GM-609 Phase Ⅱ Genervon Amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), Ischemic stroke Details
HM-12470 HM-12470A; SAR-440067; LAPS Insulin 115 Phase Ⅰ Hanmi, Sanofi Type 1 diabetes, Type 2 diabetes Details
Insulin inhalation (Lilly/Dura Pharmaceuticals) Phase Ⅱ Dura Pharmaceuticals, Lilly Type 1 diabetes, Type 2 diabetes Details
Insulin 320 OI320GT; NN-1957 Phase Ⅰ Novo Nordisk Type 2 diabetes Details
Insulin aspart biosimilar (Biocon/Mylan) MYL-1601D Phase Ⅲ Biocon, Mylan Type 1 diabetes Details
Semaglutide/Insulin 287 NNC0148-0287sema Phase Ⅰ Novo Nordisk Type 2 diabetes Details
Recombinant human insulin (Eastgate Biotech) EGP-1214,EGP1214,EGP 1214 Phase Not Specified Eastgate Biotech Type 2 diabetes, Prediabetes Details
XOMA-358 XOMA-358; XOMA-247; XPA.15.247 Phase Ⅱ Xoma Hyperinsulinaemia, Hypoglycemia Details
Insulin inhaled (Coremed) Phase Ⅰ CoreMed, Wanbang Biopharmaceuticals, Fosun Pharma Diabetes Details
MBL protein (Bridge BioResearch) Phase Ⅰ Bridge BioResearch Type 2 diabetes Details
Insulin (Coremed) Phase Ⅰ CoreMed Diabetes Details
Insulin intranasal (Marina Biotech) Phase Ⅱ Marina Biotech, Autotelic Type 2 diabetes Details
NN-1952 NN-1952 Phase Ⅰ Novo Nordisk, Merrion Pharmaceuticals Diabetes Details
Basal insulin Fc (Eli Lilly) Phase Ⅰ Lilly Diabetes Details
Insulin aspart biosimilar (Tonghua Dongbao Pharmaceutical) Phase Ⅲ Tonghua Dongbao Pharmaceutical Diabetes Details
Insulin inhalation (Dong Sung/Biocon) Phase Ⅱ Biocon BioPharmaceuticals, DongSung Pharm Type 1 diabetes Details
Insuman U-400 BLA Filing Sanofi Type 1 diabetes Details
AKP-11 AKP-11,AKP11 Phase Ⅱ Akaal Pharma Plaque psoriasis Details
Insulin oral (Provalis) Phase Ⅱ Provalis Type 1 diabetes, Type 2 diabetes Details
Insulin (transoral) (Noven Pharmaceuticals) Phase Ⅰ Hisamitsu Pharmaceutical Type 1 diabetes Details
NP-01 (Medesis Pharma SA) NP01 Phase Ⅰ Medesis Pharma SA Type 2 diabetes Details
Oral insulin (Orin Pharmaceuticals) Phase Ⅱ Orin Pharmaceuticals Type 2 diabetes Details
BIOD-125 (Biodel) Phase Ⅰ Albireo Type 1 diabetes Details
Hepatoselective insulin (BTG/King's College London) Phase Ⅰ King's College London, BTG plc Type 1 diabetes Details

This web search service is supported by Google Inc.

totop